Why Microneedles Still Matter in Drug Delivery

Two men, Nick A. (left) and Nigel (right), sit at a white table, engaging in a lively and friendly conversation. Both wear checkered shirts and lavalier microphones, suggesting a filmed discussion or interview. Nick holds tissue samples in one hand and gestures animatedly, while Nigel smiles in response. Each has a white mug labeled with their name and a purple star logo. The background is a bright white, creating a clean and professional studio setting.
Resources

Why Microneedles Still Matter in Drug Delivery

YouTube video thumbnail

In this episode of Bio Break, Nigel and Nick explore microneedle drug delivery—a growing field in medtech that aims to improve patient comfort and treatment compliance. While the term “microneedles” may sound futuristic, this technology has been around for years. The goal? Deliver medicine through the skin with less pain, less fear, and fewer barriers to care.

What Is Microneedle Drug Delivery?

Microneedles are tiny structures, often as small as a human hair, that can puncture the skin’s outer layer to administer medication. Some dissolve into the skin, while others act as miniature hollow syringes. Unlike traditional injections, microneedle drug delivery can avoid deeper nerve endings—meaning less pain for the patient.

Advantages Over Traditional Injections

The key benefit of microneedles is improved patient compliance. Many people skip essential treatments due to needle anxiety. By minimizing discomfort, microneedles make it easier for patients to stick with treatment plans. This approach could be especially useful for vaccines, hormone therapies, or chronic care where regular administration is needed.

Limitations and Drug Compatibility

Not all medications are suitable for microneedle delivery. Larger molecules may not pass through the tiny channels or could be damaged by shear forces. Product developers must consider drug formulation, molecule size, and delivery speed when selecting this method.

Future Outlook and Applications

Microneedle drug delivery has potential in both consumer health and clinical use, but widespread adoption depends on finding scalable applications. The technology continues to evolve, particularly in pairing with biologics and nanoparticles.

Learn more about StarFish Medical.

Older woman at home checking a smartwatch while managing medications, illustrating remote monitoring medical devices in daily life

Remote Monitoring: Promises and Reality

Connected health devices are multiplying fast. We examine the gap between remote monitoring’s promise and its reality.

Two people seated at a table holding handheld medical device prototypes, with text overlay reading "Is It Ready for a Human?" — MedDevice by Design episode on clinical prototypes for human use

Clinical Prototypes for Human Use: What You Need to Know

Ariana and Mark walk through what separates a clinical prototype from a proof-of-concept build, what determines how much testing and documentation you actually need, and where the regulatory line between significant risk and non-significant risk falls.

Nick and Nigel each holding a different USPTO patent certificate, illustrating the difference between a design patent and a utility patent in a Bio Break episode

Design Patent vs Utility Patent: What’s the Difference?

In this episode of Bio Break, Nick walks through both patent types after receiving two of his own in the mail, one of each, from the USPTO.

Mickey Urdea and Scott Phillips headshots for MedTech Unscripted exit strategy webinar

Built for Exit: What Drives MedTech Success

Scott Phillips sits down with Mickey Urdea to examine what actually distinguishes companies that reach commercial outcomes from those that do not.